THOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING has a total of 19 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are FOCHON PHARMACEUTICALS LTD, ENYO PHARMA and SUZHOU KINTOR PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Brazil | 2 | |
#6 | China | 1 | |
#7 | United Kingdom | 1 | |
#8 | New Zealand | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Helleday Thomas | 14 |
#2 | Scobie Martin | 10 |
#3 | Wallner Olov | 7 |
#4 | Koolmeister Tobias | 7 |
#5 | Homan Evert | 6 |
#6 | Sandberg Lars | 5 |
#7 | Haraldsson Martin | 5 |
#8 | Bengtsson Christoffer | 5 |
#9 | Stenmark Pål | 5 |
#10 | Henriksson Martin | 5 |
Publication | Filing date | Title |
---|---|---|
CN112074511A | Substituted benzodiazoles and their use in therapy | |
GB201806349D0 | New compounds and uses | |
AU2016307448A1 | Method for diagnosing cancer or cancer-associated thrombosis by measuring levels of H3Cit in plasma | |
NZ709094A | Pyrimidine-2,4-diamine derivatives for treatment of cancer |